tiprankstipranks
Aligos Therapeutics (ALGS)
NASDAQ:ALGS

Aligos Therapeutics (ALGS) Cash flow

75 Followers

Aligos Therapeutics Cash Flow

ALGS's free cash flow for Q3 2023 was $-20.38M. For the 2023 fiscal year, ALGS's free cash flow was decreased by $36.22M and operating cash flow was $-20.38M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 22Dec 21Dec 20Dec 19Dec 18
Operating Cash Flow
$ -73.14M$ -79.39M$ -115.66M$ -74.26M$ -46.77M$ -6.05M
Investing Cash Flow
$ 56.59M$ -26.29M$ 3.02M$ 32.76M$ 6.79M$ -69.29M
Financing Cash Flow
$ 493.00K$ 164.00K$ -954.00K$ 192.35M$ 85.53M$ 99.89M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 242.34M$ 81.46M$ 107.35M$ 220.94M$ 70.10M$ 24.55M
Income Tax Paid Supplemental Data
---$ 0.00$ 1.00K$ 0.00
Interest Paid Supplemental Data
---$ 0.00$ 6.00K$ 0.00
Issuance Of Capital Stock
$ 555.00K$ 205.00K-$ 195.54M$ 84.96M$ 94.81M
Issuance Of Debt
$ -65.00K$ -61.00K$ -79.00K-$ 0.00$ 5.00M
Repayment Of Debt
$ -65.00K$ -61.00K$ -79.00K$ -58.00K$ -43.00K$ -1.00K
Free Cash Flow
$ -73.23M$ -80.33M$ -116.55M$ -76.33M$ -49.55M$ -8.56M
Domestic Sales
------
Foreign Sales
------
Currency in USD

Aligos Therapeutics Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis